Drugs / spirulina-derived exosomes
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT07324018 | Jan → Jun 2026 overdue | — | West China Hospital | Not yet recruiting | No outcome recorded |
| Phase 2 | NCT07040969 | Jun 2025 → Jan 2026 overdue | mucositis | West China Hospital | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | spirulina-derived exosomes | “An oral spray formulated with purified spirulina-derived exosomes.” NCT07040969 ↗ |
| Route | Oral | “Participants will be instructed to orally administer the spirulina-derived product or placebo spray four times daily” NCT07040969 ↗ |